Return to: Academic Health Center : myAHC : U of M Home

Gold University of Minnesota M. Skip to main content.University of Minnesota. Home page.
 
Physiology. Medical School.

What's inside.

Who's Who

Graduate Studies

Undergraduate Studies

Course Offerings

Short Courses for People in Biomedical Industry

Seminars

Anatomy Program

Machine Shop

IBP Biotech Faculty Group

Job Openings

Links of interest

Department of Integrative Biology & Physiology
University of Minnesota
Medical School
6-125 Jackson Hall
321 Church Street SE
Minneapolis, MN 55455

phone 612.625.5902
fax 612.625.5149

Questions about this site? Contact the Physiology Department at 612.625.5902 or physio@umn.edu.

 
  Home > Faculty Research Interests > David G. Levitt, M.D., Ph.D.
 
 

David G. Levitt, M.D., Ph.D.

Professor of Physiology


I have been involved in research in large number of areas of physiology and biophysics, including: capillary exchange, small intestinal circulation and absorption, blood-tissue exchange kinetics, membrane and ion channel biophysics, ethanol pharmacokinetics, and X-ray crystallography. My current area of research interest is in pharmacokinetics, which makes use of my background in these varied fields. I recently developed PKQuest (www.pkquest.com), a new pharmacokinetic software program. I am now focused on the further development of this program and its application to a number of pharmacokinetic research areas.

Pharmacokinetic Publications:


Levitt DG. PKQUEST: Capillary Permeability Limitation and Plasma Protein Binding - Application to Human Inulin, Dicloxacillin and Ceftriaxone Pharmacokinetics. BMC Clin Pharmacol. 2002 Sep 26

Levitt DG. PKQuest: volatile solutes - application to enflurane, nitrous oxide, halothane, methoxyflurane and toluene pharmacokinetics.BMC Anesthesiol. 2002 Aug 15;2(1):5.

Levitt DG. PKQuest: measurement of intestinal absorption and first pass metabolism - application to human ethanol pharmacokinetics.BMC Clin Pharmacol. 2002 Aug 15;2(1):4.

Levitt DG. PKQuest: a general physiologically based pharmacokinetic model. Introduction and application to propranolol. BMC Clin Pharmacol. 2002 Aug 15;2(1):5.

Levitt, DG. The Use of a Physiologically Based Pharmacokinetic Model to Evaluate Deconvolution Measurements of Systemic Absorption. BMC Clin Pharmacol. 2003, 3:1 (19 Mar 2003).

Levitt, DG. The Pharmacokinetics of the Interstitial Space in Humans. BMC Clin Pharmacol. Submitted.

Click here for Complete Publication List


Dr. David Levitt can be reached at:  levit001@umn.edu
 
The University of Minnesota is an equal opportunity educator and employer.